Mounjaro After Gastric Sleeve: Safety, Benefits and Clinical Guidance Written by Bolt Pharmacy Published 30/7/2025 Last Updated 25/5/2026 Mounjaro (tirzepatide) is a dual GIP/GLP-1 receptor agonist licensed in the UK for type 2 diabetes, with emerging use in weight management. Gastric sleeve surgery remains a cornerstone bariatric procedure for significant, sustained weight loss. Some patients […]
Monthly Archives: August 2026
How to Open Mounjaro: Step-by-Step Pen Injection Guide Written by Bolt Pharmacy Published 5/11/2025 Last Updated 24/6/2026 Mounjaro (tirzepatide) is a once-weekly injectable medication for type 2 diabetes, supplied as a pre-filled, single-use pen. Understanding how to open Mounjaro correctly is essential for safe, effective administration. The pen features a simple design: removing the clear […]
Loopy Off the Mounjaro: Causes, Safety, and Management Written by Bolt Pharmacy Published 6/11/2025 Last Updated 16/4/2026 Feeling ‘loopy’ on Mounjaro (tirzepatide) is a colloquial term some patients use to describe dizziness, light-headedness, mental fog, or disorientation during treatment. Mounjaro is a dual GIP and GLP-1 receptor agonist licensed in the UK for type 2 […]
Mounjaro in the Arm: Safe Injection Sites and Technique Written by Bolt Pharmacy Published 5/11/2025 Last Updated 16/4/2026 Mounjaro (tirzepatide) is a dual GIP and GLP-1 receptor agonist licensed in the UK for type 2 diabetes mellitus, administered via once-weekly subcutaneous injection. Many patients wonder whether Mounjaro can be injected in the arm, particularly if […]
Mounjaro and Bodybuilding: Safety, Risks and Medical Guidance Written by Bolt Pharmacy Published 30/10/2025 Last Updated 16/4/2026 Mounjaro (tirzepatide) is a prescription medicine licensed in the UK for treating type 2 diabetes mellitus, with significant weight loss effects observed in clinical trials. Some bodybuilders and athletes have shown interest in using tirzepatide during cutting phases […]
Mounjaro and Colon Cancer: Evidence, Risk and Safety Guidance Written by Bolt Pharmacy Published 30/10/2025 Last Updated 21/5/2026 Mounjaro (tirzepatide) is a dual GIP and GLP-1 receptor agonist licensed in the UK for type 2 diabetes and weight management. Recent discussions have raised questions about Mounjaro and colon cancer risk, prompting concern amongst patients and […]
Does Mounjaro Cause Fever? UK Clinical Guidance Written by Bolt Pharmacy Published 31/10/2025 Last Updated 16/4/2026 Mounjaro (tirzepatide) is a dual GLP-1 and GIP receptor agonist licensed in the UK for type 2 diabetes mellitus. Patients and clinicians often ask: does Mounjaro cause fever? Fever is not listed as a common side effect in the […]
Mounjaro: What Supplements to Take During Treatment Written by Bolt Pharmacy Published 14/10/2025 Last Updated 2/6/2026 Mounjaro (tirzepatide) is a dual GLP-1 and GIP receptor agonist licensed in the UK for type 2 diabetes management, with significant effects on appetite and gastric emptying. Many patients wonder what supplements to take with Mounjaro to support nutritional […]
Loopy Off the Mounjaro: Causes, Safety, and Management Written by Bolt Pharmacy Published 6/11/2025 Last Updated 16/4/2026 Feeling ‘loopy’ on Mounjaro (tirzepatide) is a colloquial term some patients use to describe dizziness, light-headedness, mental fog, or disorientation during treatment. Mounjaro is a dual GIP and GLP-1 receptor agonist licensed in the UK for type 2 […]
What Colour Is Mounjaro? UK Pen Identification Guide Written by Bolt Pharmacy Published 27/10/2025 Last Updated 16/4/2026 Mounjaro (tirzepatide) is a once-weekly injectable medication licensed in the UK for type 2 diabetes and weight management. The pre-filled pens use a colour-coded system to help identify different dosage strengths—2.5 mg, 5 mg, 7.5 mg, 10 mg, […]